Abstract
Since its isolation by Carswell et al. in 1975 [1] as the agent responsible for hemorrhagic necrosis of sarcoma, the tumor necrosis factor (TNF-α) has been implicated in a variety of physiological activities. Studies in animal models and humans have shown that at least one of the cytokine’s antitumor actions is mediated through these inflammatory mechanisms, leading to hemorrhagic necrosis of tumors [2]. The successful cloning of TNF-α DNA in 1985 [3] and production of recombinant TNF-α (rTNF-α) was followed by an increase in research to more clearly define the specific actions of the cytokine. In vitro, rTNF-α was shown to increase neutrophil adherence to endothelial cells, induce an adhesion-dependent migration of neutrophils through endothelial monolayers, enhance endothelial susceptibility to neutrophil-mediated killing, and stimulate neutrophil respiratory burst and degranulation [4,5]. The mechanism of TNF-α’s action, therefore, is thought to be through neutrophils which, when stimulated by TNF-α, release H2O2, resulting in the production of tissue-damaging oxygen radicals [6]. TNF-α may also be directly cytotoxic for tumor cells through stimulation of the production of oxygen radicals in the cells themselves [7].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Nat Acad Sci USA 72: 3666–3670
Asher A, Mule JJ, Reichert CM, Shiloni E, Rosenberg SA (1987) Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 138: 963–974
Shirai T, Tamaguchi H, Ito H, Todd CW, Wallance B (1985) Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature 313: 803–806
Moser R, Schleiffenbaum B, Groscurth P, Fehr J (1989) Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83: 444–455
Varani J, Bendelow MJ, Sealey DE, Kunkel SL, Gannon DE, Ryan US, Ward PA (1988) Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Lab Invest 59: 292–295
Shau H (1988) Characteristics and mechanism of neutrophil-mediated cytostasis induced by tumor necrosis factor. J Immunol 141: 234–240
Neal ML, Fiera RA, Matthews N (1988) Involvement of phospholipase A2 activation in tumor cell killing by tumor necrosis factor. Immunology 64: 81–85
Kimura K, Taguchi T, Urushizaki I, Ohno R, Abe O, Furue H, Hattori T, Ichihashi I, Inoguchi K, Majima H, Niitani H, Ota K, Saito T, Suga S (1987) The A-TNF Cooperative Study Group: Phase I study of recombinant human tumor necrosis factor. Cancer Chemother Pharmacol 20: 223–229
Flectcher WH, Shiu WW, Ishada TA, Haviland DL, Ware CF (1987) Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells. J Immunol 139: 956–962
Selmaji KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339–346
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Tokyo
About this chapter
Cite this chapter
Kido, G., Nakamura, S., Tsubokawa, T., Merchant, R.E., Young, H.F. (1991). Acute Effects of the Human Recombinant Tumor Necrosis Factor (rTNF) on the Cerebral Vasculature of the Rat in Both Normal Brain and an Experimental Glioma Model. In: Tabuchi, K. (eds) Biological Aspects of Brain Tumors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68150-2_28
Download citation
DOI: https://doi.org/10.1007/978-4-431-68150-2_28
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-68152-6
Online ISBN: 978-4-431-68150-2
eBook Packages: Springer Book Archive